"$SRPT - Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram Presents Limb-Girdle Muscular Dystrophy Type 2E Functional Results (Transcript). Get more updates here: https://t.co/RJ0WsVhSkP #finance #investing #stockmarket"Read full news